Evidence map›Paper›PMID 29218508›Full record

ArticleArchives of toxicology2018

Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals?

Monika Waldherr, Miroslav Mišík, Franziska Ferk, Jana Tomc, Bojana Žegura, Metka Filipič, Wolfgang Mikulits, Sören Mai, Oskar Haas, Wolfgang W Huber and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Glucose coated FeO@FeScientific reports · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Application of HepaRG cells for genotoxicity assessment: a review.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Frontiers in oncology · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Monika WaldherrDepartment of Internal Medicine I, Institute of Cancer Research, Medical University Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
Miroslav MišíkDepartment of Internal Medicine I, Institute of Cancer Research, Medical University Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
Franziska FerkDepartment of Internal Medicine I, Institute of Cancer Research, Medical University Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
Jana TomcDepartment for Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, Ljubljana, Slovenia.
Bojana ŽeguraDepartment for Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, Ljubljana, Slovenia.
Metka FilipičDepartment for Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, Ljubljana, Slovenia.
Wolfgang MikulitsDepartment of Internal Medicine I, Institute of Cancer Research, Medical University Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
Sören MaiLabdia Labordiagnostik GmbH, Zimmermannplatz 8, 1090, Vienna, Austria.
Oskar HaasLabdia Labordiagnostik GmbH, Zimmermannplatz 8, 1090, Vienna, Austria.
Wolfgang W HuberDepartment of Internal Medicine I, Institute of Cancer Research, Medical University Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
Elisabeth HaslingerDepartment of Internal Medicine I, Institute of Cancer Research, Medical University Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
Siegfried KnasmüllerDepartment of Internal Medicine I, Institute of Cancer Research, Medical University Vienna, Borschkegasse 8a, 1090, Vienna, Austria. siegfried.knasmueller@meduniwien.ac.at.
Medical University of Vienna · ATNational Institute of Biology · SIJožef Stefan International Postgraduate School · SI

Funding

Austrian Science Fund FWF I 2059COST Action CA15132Javna Agencija za Raziskovalno Dejavnost RS ARRS-J1-6730
6 · The paper itself

Abstract

Cell lines which are currently used in genotoxicity tests lack enzymes which activate/detoxify mutagens. Therefore, rodent-derived liver preparations are used which reflect their metabolism in humans only partly; as a consequence misleading results are often obtained. Previous findings suggest that certain liver cell lines express phase I/II enzymes and detect promutagens without activation; however, their use is hampered by different shortcomings. The aim of this study was the identification of a suitable cell line. The sensitivity of twelve hepatic cell lines was investigated in single cell gel electrophoresis assays. Furthermore, characteristics of these lines were studied which are relevant for their use in genotoxicity assays (mitotic activity, p53 status, chromosome number, and stability). Three lines (HuH6, HCC1.2, and HepG2) detected representatives of five classes of promutagens, namely, IQ and PhIP (HAAs), B(a)P (PAH), NDMA (nitrosamine), and AFB

Indexed as

Aflatoxin B1Benzo(a)pyreneCell Line, TumorDimethylnitrosamineHumansHydrogen PeroxideImidazolesInactivation, MetabolicLiverMutagenicity TestsMutagensQuinolinesReactive Oxygen SpeciesTumor Suppressor Protein p532-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine2-amino-3-methyl-3H-imidazo(4,5-f)quinolineAflatoxin B1Benzo(a)pyreneDimethylnitrosamineHydrogen PeroxideImidazolesMutagensQuinolinesReactive Oxygen SpeciesTP53 protein, humanTumor Suppressor Protein p53Comet assayGenotoxicityHepatic cell linesp53

Identifiers

PMID29218508
PMCPMC5818615
OpenAlexW2771419401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.